960402-65-7

Basic information

• Product Name: (+/-)-3-{4-[2-(4-chloro-phenyl)-7-oxo-7H-thieno[2,3-c]pyridin-6-yl]-phenylcarbamoyl}-pyrrolidine-1-carboxylic acid tert-butyl ester
• Synonyms: (+/-)-3-{4-[2-(4-chloro-phenyl)-7-oxo-7H-thieno[2,3-c]pyridin-6-yl]-phenylcarbamoyl}-pyrrolidine-1-carboxylic acid tert-butyl ester
• CAS NO: 960402-65-7
• Molecular Weight: 550.078
• Mol File: 960402-65-7.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (+/-)-3-{4-[2-(4-chloro-phenyl)-7-oxo-7H-thieno[2,3-c]pyridin-6-yl]-phenylcarbamoyl}-pyrrolidine-1-carboxylic acid tert-butyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: (+/-)-3-{4-[2-(4-chloro-phenyl)-7-oxo-7H-thieno[2,3-c]pyridin-6-yl]-phenylcarbamoyl}-pyrrolidine-1-carboxylic acid tert-butyl ester(960402-65-7)
• EPA Substance Registry System: (+/-)-3-{4-[2-(4-chloro-phenyl)-7-oxo-7H-thieno[2,3-c]pyridin-6-yl]-phenylcarbamoyl}-pyrrolidine-1-carboxylic acid tert-butyl ester(960402-65-7)

Safety Data

• Hazardous Substances Data: 960402-65-7(Hazardous Substances Data)

Upstream product

• 14470-51-0 5,6-dihydrothieno[2,3-c]pyridin-7(4H)-one 
• 1679-18-1 4-Chlorophenylboronic acid 
• 960289-06-9 5-(4-chlorophenyl)-thiophene-2-carboxylic acid (2,2-diethyoxyethyl)amide 
• 960289-07-0 5-(4-chlorophenyl)-thiophene-2-carboxylic acid (2-oxoethyl)amide 
• 960289-03-6 2-bromo-5,6-dihydro-4H-thieno[2,3-c]pyridin-7-one 
• 960289-02-5 (2-thiophen-3-yl-ethyl)-carbamic acid ethyl ester 
• 5650-52-2 4,5-dihydro-6H-cyclopenta[b]thiophen-6-one 
• 960289-27-4 2-(4-chloro-phenyl)-6H-thieno[2,3-c]pyridin-7-one 
• 24065-33-6 5-Chlorothiophene-2-carboxylic acid 
• 960402-40-8 6-(4-bromo-phenyl)-2-(4-chloro-phenyl)-6H-thieno[2,3-c]pyridin-7-one 
• 122684-34-8 1-tert-<(butyloxy)carbonyl>-3-carbamoylpyrrolidine 

Downstream Products

• 960402-67-9 (+/-)-2-(4-chloro-phenyl)-6-[3-methoxy-4-(pyrrolidine-3-carbonyl)-phenyl]-6H-thieno[2,3-c]pyridin-7-one trifluoroacetic acid 

Relevant articles and documents

NOVEL MCH RECEPTOR ANTAGONISTS

The present invention relates to a melanin concentrating hormone antagonist compound of formula (I): wherein R1, Ra, Rb, R2, L1, R3, R4 and R5 are as defined, or a pharmaceutically acceptable salt, enantiomer, diastereomer or mixture of diasteromers thereof useful in the treatment, obesity and related diseases.